Search | VHL Regional Portal

Suggestion of Tunisia's medical oncologist in the management of breast cancer during COVID-19 pandemic.

Yahyaoui, Yosra; Ghodhbani, Zahra; Hamdi, Adel; Letaief, Feryel; Zenzri, Yosr; Ben Said, Azza; Blouza, Imen; Mezlini, Amel.

J Oncol Pharm Pract ; 26(7): 1732-1734, 2020 Oct.

Article in English | MEDLINE | ID: mdl-32791938

ABSTRACT

Cancer patients are at higher risk to be infected with COVID-19 and to develop a more severe form. Breast cancer (BC) treatments, including chemotherapy (CT), targeted therapy and immunotherapy can weaken the immune system and possibly cause lung problems. For all these reasons Salah Azaiez Institute's department of Medical Oncology took drastic actions to protect patients. In this article we will discuss protocol adjustments taken during the COVID-19 pandemic for breast cancer patients.

Subject(s)

Antineoplastic Protocols , Breast Neoplasms , Communicable Disease Control , Coronavirus Infections , Medical Oncology/trends , Pandemics , Patient Care Management , Pneumonia, Viral , Betacoronavirus , Breast Neoplasms/epidemiology , Breast Neoplasms/pathology , Breast Neoplasms/therapy , COVID-19 , Communicable Disease Control/methods , Communicable Disease Control/organization & administration , Coronavirus Infections/epidemiology , Coronavirus Infections/prevention & control , Female , Humans , Neoplasm Staging , Organizational Innovation , Pandemics/prevention & control , Patient Care Management/methods , Patient Care Management/organization & administration , Pneumonia, Viral/epidemiology , Pneumonia, Viral/prevention & control , Risk Adjustment/methods , SARS-CoV-2 , Telemedicine/methods , Tunisia/epidemiology

ABSTRACT

Subject(s)

SEND TO:

SELECTION OF CITATIONS

SEARCH DETAIL